Inappropriate drug prescription at nursing home admission

Journal of the American Medical Directors Association

Volumn 13, Issue 1, 2012, Pages 83.e9-83.e15

  García Gollarte, Fermín ^a   Baleriola Júlvez, José ^a   Ferrero López, Isabel ^b   Cruz Jentoft, Alfonso J ^c  

^a UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^b Pare Jofre Hospital   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Appropriateness; Drug use; Geriatric pharmacotherapy; Nursing homes

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CODEINE PHOSPHATE; CORTICOSTEROID; DIGOXIN; DILTIAZEM; DIPHENOXYLATE; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; LOPERAMIDE; METOCLOPRAMIDE; MORPHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROCHLORPERAZINE; PROTON PUMP INHIBITOR; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL; VITAMIN D; WARFARIN;

AGED; ANKLE EDEMA; ARTICLE; AUSTRALIAN CRITERIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DIARRHEA; DRUG INDICATION; DRUG USE; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MEDICAL ERROR; NURSING HOME; NURSING HOME PATIENT; PAIN; PEPTIC ULCER; SCREENING TOOL OF OLDER PERSON POTENTIALLY INAPPROPRIATE PRESCRIPTION CRITERIA; SCREENING TOOL TO ALERT DOCTORS TO THE RIGHT TREATMENT CRITERIA;

EID: 84855202026     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2011.02.009     Document Type: Article

References (62)

1. Salgado A., Ruipérez I., Sepúlveda D. Valoración geriátrica integral: Conceptos generales. Beneficios de la intervención. Grupos de riesgo. Manual de Geriatría 2002, 223-229. Masson, Barcelona. 3rd ed. A. Salgado, F. Guillén, I. Ruipérez (Eds.).
2. Cepeda O., Morley J. Polypharmacy, is this another disease?. Principles and Practice of Geriatric Medicine 2006, 329-346. John Wiley & Sons, Chichester, UK. 4th ed. J. Pathy, A. Sinclair, J. Morley (Eds.).
3. Hanlon J.T., Schmader K.E., Koronkowski M.J., et al. Adverse drug events in high risk older outpatients. JAm Geriatr Soc 1997, 45:945-948.
4. Klarin I., Wimo A., Fastbom J. The association of inappropriate drug use with hospitalisation and mortality. Drugs Aging 2005, 22:69-82.
5. Ackermann R.J., Meyer von Bremen G.B. Reducing polypharmacy in the nursing home: An activist approach. JAm Board Fam Pract 1995, 8:195-205.
6. Beers M.H., Fingold S.F., Ouslander J.G., et al. Characteristics and quality of prescribing by doctors practicing in nursing homes. JAm Geriatr Soc 1993, 41:802-807.
7. Nguyen J.K., Fouts M.M., Kotabe S.E., et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006, 4:36-41.
8. Rochon P.A., Gurwitz J.H. Prescribing for seniors: Neither too much nor too little. JAMA 1999, 282:113-115.
9. Avorn J., Gurwitz J.H., Rochon P. Principles of pharmacology. Geriatric Medicine: An Evidence-based Approach 2002, 65-81. Springer, New York. 4th ed. C.K. Cassel, R.M. Leipzig, H.J. Cohen (Eds.).
10. Gurwitz J.H. Polypharmacy. A new paradigm for quality drug therapy in the elderly. Arch Intern Med 2004, 164:1957-1959.
11. Consejo General de Colegios Oficiales de Farmacéuticos. Estadísticas Sanitarias 2008, Available at:, Accessed September 12, 2010. http://www.portalfarma.com/pfarma/taxonomia/general/gp000016.nsf/voDocumentos/120C1F228EDEF914C125764E00352390/$File/estadisticas_sanitarias.pdf.
12. OECD Statistics. Available at: Accessed August 22, 2010. http://www.oecd.org/publications/0,3353,en_2649_201185_1_1_1_1_1,00.html.
13. Lewis L. Reduce polypharmacy and boost appropriate drug use. JAm Med Dir Assoc 2001, 2:H36-H37.
14. Spinewine A., Schmader K.E., Barber N., et al. Appropriate prescribing in elderly people: How well can it be measured and optimised?. Lancet 2007, 370:173-184.
15. De Smet P., Denneboom W., Kramers C., et al. Acomposite screening tool for medication reviews of outpatients. General issues with specific examples. Drugs Aging 2007, 24:733-760.
16. Straand J., Fetveit A., Rognstad S., et al. Acluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice-The Prescription Peer Academic Detailing (Rx-PAD) study. BMC Health Serv Res 2006, 6:72. [NCT00281450].
17. Tangiisuran B., Wright J., Van der Cammen T., et al. Adverse drug reactions in elderly: Challenges in identification and improving preventative strategies. Age Ageing 2009, 38:358-359.
18. Beers M.H., Ouslander J.G., Rollingher I., et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991, 151:1825-1832.
19. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003, 163:2716-2724.
20. Naugler C.T., Brymer C., Stolee P., et al. Development and validation of an improved prescribing for the elderly tool. Can J Clin Pharmacol 2000, 7:103-107.
21. Hanlon J.T., Schmader K.E., Samsa G.P., et al. Amethod for assessing drug therapy appropriateness. JClin Epidemiol 1992, 45:1045-1051.
22. Shekelle P.G., MacLean C.H., Morton S.C., et al. Acove quality indicators. Ann Intern Med 2001, 135:653-667.
23. Knight E.L., Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001, 135:703-710.
24. Barry P.J., Gallagher P., Ryan C. Inappropriate prescribing geriatric patients. Curr Psychiatry Rep 2008, 10:37-43.
25. Gallagher P., Ryan C., Byrne S., et al. STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment): Consensus validation. Int J Clin Pharmacol Ther 2008, 46:72-83.
26. Gallagher P., O'Mahony D. STOPP (Screening Tool of Older Persons potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37:673-679.
27. Delgado Silveira E., Muñoz García M., Montero Errasquin B., et al. Prescripción inapropiada de medicamentos en los pacientes mayores. Los criterios STOPP/START. Rev Esp Geriatr Gerontol 2009, 44:273-279.
28. Lang P.O., Hasso Y., Belmin J., et al. STOPP-START: Adaptation en langue francaise d'un outil de detection de la prescription medicamente use inapproprièe chez la personne agèe. Can J Public Health 2009, 100:426-431.
29. Topinková E., Mádlová P., Fialová D., et al. Nova evidence-based kriteria pro posouzeni vhodnosti lekoveho rezimu u senioru. Kriteria STOPP (Screening Tool of Older Person's Prescriptions) a START (Screening Tool to Alert doctors to Right Treatment). Vnitr Lek 2008, 54:1161-1169.
30. Basger B.J., Chen T.F., Moles R.J. Inappropriate medication use and prescribing indicators in elderly Australians: Development of a prescribing indicators tool. Drugs Aging 2008, 25:777-793.
31. Sicras Mainar A., Peláez-de-Loño, Castellá R., et al. Eficacia de una intervención en la adecuación del uso de medicamentos en centros residenciales geriátricos. Resultados a los tres años de su implantación. Rev Esp Geriatr Gerontol 2007, 42:5-15.
32. Gongora L., Puche E., García J., Luna J.D. Prescripciones inapropiadas en ancianos institucionalizados. Rev Esp Geriatr Gerontol 2004, 39:19-24.
33. Dhalla I.A., Anderson G.M., Mamdani M.M., et al. Inappropriate prescribing before and after nursing home admission. JAm Geriatr Soc 2002, 50:995-1000.
34. Beers M.H., Ouslander J.G., Fingold S.F., et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992, 117:684-689.
35. Conejos Miquel M.D., Sánchez-Cuervo M., Delgado-Sivera E., et al. Potentially inappropriate drug prescription in older subjects across health care settings. European Geriatric Medicine 2010, 1:9-14.
36. Mahoney F.I., Barthel D.W. Functional evaluation: The Barthel Index. Md State Med J 1965, 4:61-65.
37. Reisberg B., Ferris S.H., de Leon M.J., et al. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982, 139:1136-1139.
38. Kaufman D.W., Kelly J.P., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002, 287:337-344.
39. Atención a personas mayores que viven en residencias. Protocolos de intervención psicosocial y sanitaria 1998, IMSERSO-SEGG, Ministerio de Trabajo y Asuntos Sociales, Madrid.
40. Ryan C., O'Mahony D., Kennedy J., et al. Appropriate prescribing in the elderly. An investigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improved prescribing in the elderly tool to identity inappropriate use of medicines in elderly in primary care in Ireland. JClin Pharm Ther 2009, 34:369-376.
41. Buck M.D., Atreja A., Bunker C.P., et al. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristicsbased on electronic health records. Am J Geriatr Pharmacother 2009, 7:84-92.
42. Carey I.M., De Wilde S., Harris T., et al. What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database. Drugs Aging 2008, 25:693-706.
43. Cárdenas-Valladolid J., Mena-Mateo J., Cañada-Dorado M.M., et al. Implantación y mejora de un programa de atención al mayor polimedicado en un área de atención primaria. Rev Calid Asist 2009, 24:24-31.
44. Hosia-Randell H.M., Muurinen S.M., Pitkälä K.H. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: A cross-sectional study. Drugs Aging 2008, 25:683-692.
45. Zuckerman I.H., Hernandez J.J., Gruber-Baldini A.L., et al. Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. Am J Geriatr Pharmacother 2005, 3:246-254.
46. Perri M., Menon A.M., Deshpande A.D., et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005, 39:405-411.
47. Tulner L.R., Frankfort S.V., Gijsen G.J., et al. Drug-drug interactions in a geriatric outpatient cohort: Prevalence and relevance. Drugs Aging 2008, 25:343-355.
48. Frazier S.C. Health outcomes and polypharmacy in elderly individuals: An integrated literature review. JGerontol Nurs 2005, 31:4-11.
49. Lang P.O., Hasso Y., Dramé M., et al. Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities. Age Ageing 2010, 39:373-381.
50. Barry P.J., Gallagher P., Ryan C., et al. START (Screening Tool to Alert doctors to the Right Treatment): An evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007, 36:632-638.
51. Montero-Errasquin B., Sánchez-Cuervo M., Sánchez-Castellano M., et al. Inappropriate prescription in geriatric outpatients: A comparison of two instruments. JNutr Health Aging 2008, 12:585. [abstract].
52. Tinetti M. Preventing falls in elderly persons. NEngl J Med 2003, 348:42-49.
53. Gray S.L., LaCroix A.Z., Hanlon J.T., et al. Benzodiazepine use and physical disability in community dwelling older adults. JAm Geriatr Soc 2006, 54:224-230.
54. Westbury J., Jackson S., Gee P., et al. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr 2010, 22:26-36.
55. Donovan J.L., Kanaan A.O., Thomson M.S., et al. Effect of clinical decision support on psychotropic medication prescribing in the long-term care setting. JAm Geriatr Soc 2010, 58:1005-1007.
56. Patterson S.M., Hughes C.M., Crealey G., et al. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study). JAm Geriatr Soc 2010, 58:44-53.
57. Dahl L.J., Wright R., Xiao A., et al. Quality improvement in long term care: The psychotropic assessment tool (PAT). JAm Med Dir Assoc 2008, 9:676-683.
58. van der Sijs H., Mulder A., van Gelder T., et al. Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf 2009, 18:941-947.
59. Ntaios G., Chatzinikolaou A., Kaiafa G., et al. Evaluation of use of proton pump inhibitors in Greece. Eur J Intern Med 2009, 20:171-173.
60. Kamel H.K. Underutilization of calcium and vitamin D supplements inanacademic long-term care facility. JAm Med Dir Assoc 2004, 5:98-100.
61. Grady D., Redberg R.F. Less is more: How less health care can result in better health. Arch Intern Med 2010, 170:749-750.
62. Cherubini A., Del Signore S., Ouslander J., et al. Fighting against age discrimination in clinical trials. JAm Geriatr Soc 2010, 58:1791-1796.